Strain-Encoded Cardiac Magnetic Resonance Imaging for Dobutamine Stress Testing
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare the diagnostic value of SENC to that provided by conventional wall motion analysis for the detection of inducible ischemia during DS-MRI.High-dose dobutamine stress magnetic resonance imaging (DS-MRI) is safe and feasible for the diagnosis of coronary artery disease (CAD) in humans. However, the assessment of cine scans relies on the visual interpretation of regional wall motion, which is subjective. Recently, Strain-Encoded MRI (SENC) has been proposed for the direct color-coded visualization of myocardial strain.
| Condition |
|---|
|
Coronary Artery Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Strain-Encoded Cardiac Magnetic Resonance Imaging as an Adjunct for Dobutamine Stress Testing. |
- Detection of coronary artery disease (>50% diameter stenosis) by invasive angiography [ Time Frame: 3 weeks ] [ Designated as safety issue: No ]
- Long-term mortality and MACE [ Time Frame: 2 years ] [ Designated as safety issue: No ]
| Enrollment: | 320 |
| Study Start Date: | January 2007 |
| Study Completion Date: | January 2011 |
| Primary Completion Date: | January 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Patients with suspected or known stable coronary artery disease
|
|
2
Healthy subjects as a control group
|
Detailed Description:
The assessment of inducible regional wall motion abnormalities during high-dose dobutamine stress magnetic resonance imaging (DS-MRI) is an established clinical method with high diagnostic and prognostic value for the evaluation of patients with coronary artery disease (CAD). However, the assessment of cine images relies on the visual interpretation of regional wall motion, which is subjective, and objective approaches for the detection of inducible ischemia with DS-MRI are still lacking.
In our study Strain-Encoded-MRI (SENC) is used for the objective color-coded evaluation of regional myocardial strain during DS-MRI in patients with intermediate to high pretest probability for CAD. We anticipated that this technique would exhibit enhanced sensitivity for the detection of anatomically significant CAD compared to conventional wall motion reading, with invasive coronary angiography used as the standard reference.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Consecutive patients with suspected or known coronary artery disease and healthy volunteers serving as a contol group.
Inclusion Criteria:
- Suspected or known coronary artery disease
Exclusion Criteria:
- General contraindication for a dobutamine stress or for an MRI examination
- Age < 18 yrs
Contacts and Locations
More Information
No publications provided by University of Heidelberg
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | G. Korosoglou, Prof. Dr., University of Heidelberg |
| ClinicalTrials.gov Identifier: | NCT00758654 History of Changes |
| Other Study ID Numbers: | MRI-021 |
| Study First Received: | September 23, 2008 |
| Last Updated: | March 28, 2012 |
| Health Authority: | Germany: Ethics Commission, University of Heidelberg. |
Keywords provided by University of Heidelberg:
|
myocardial strain Strain-Encoded MRI dobutamine stress MRI ischemia strain rate reserve |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Heart Diseases Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Dobutamine Cardiotonic Agents Cardiovascular Agents Therapeutic Uses |
Pharmacologic Actions Sympathomimetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Adrenergic beta-1 Receptor Agonists Adrenergic beta-Agonists Adrenergic Agonists Adrenergic Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Protective Agents |
ClinicalTrials.gov processed this record on May 23, 2013